Emerging evidence suggests a complex relationship between sphingosine 1-phosphate (S1P) signaling and stroke. Here, we show the kinetics of S1P in the acute phase of ischemic stroke and highlight accompanying changes in immune cells and S1P receptors (S1PR). Using a C57BL/6 mouse model of middle cerebral artery occlusion (MCAO), we assessed S1P concentrations in the brain, plasma, and spleen. We found a steep S1P gradient from the spleen towards the brain. Results obtained by qPCR suggested that cells expressing the S1PR type 1 (S1P1+) were the predominant population deserting the spleen. Here, we report the cerebral recruitment of T helper (TH) and regulatory T (TREG) cells to the ipsilateral hemisphere, which was associated with different...
Arterial ischemic stroke is common in neonates-1 per 2,300-5,000 births-and therapeutic targets rema...
Background and Purpose Collateral growth after acute occlusion of an intracranial artery is triggere...
Acute ischemic stroke (AIS) is a neurological disease caused by cessation of blood flow to the brain...
Emerging evidence suggests a complex relationship between sphingosine 1-phosphate (S1P) signaling an...
Medically relevant roles of receptor-mediated sphingosine 1-phosphate (S1P) signaling have become a ...
The use and effectiveness of current stroke reperfusion therapies are limited by the complications o...
Background and Purpose—We have previously shown that the sphingosine 1-phosphate (S1P)/S1P receptor-...
Cerebral ischemia is accompanied by fulminant cellular and humoral inflammatory changes in the brain...
International audienceRationale: Cerebrovascular function is critical for brain health, and endogeno...
The two ubiquitously expressed sphingosine kinases (SphK) 1 and 2 are key regulators of the sphingol...
Collateral growth after acute occlusion of an intracranial artery is triggered by increasing shear s...
Sphingosine 1-phosphate (S1P), derived from membrane sphingolipids, is a pleiotropic bioactive lipid...
Collateral growth after acute occlusion of an intracranial artery is triggered by increasing shear s...
Sphingosine 1-phosphate (S1P), derived from membrane sphingolipids, is a pleiotropic bioactive lipid...
[Background and Purpose] Growing evidence supports that the immunomodulatory drug fingolimod is prot...
Arterial ischemic stroke is common in neonates-1 per 2,300-5,000 births-and therapeutic targets rema...
Background and Purpose Collateral growth after acute occlusion of an intracranial artery is triggere...
Acute ischemic stroke (AIS) is a neurological disease caused by cessation of blood flow to the brain...
Emerging evidence suggests a complex relationship between sphingosine 1-phosphate (S1P) signaling an...
Medically relevant roles of receptor-mediated sphingosine 1-phosphate (S1P) signaling have become a ...
The use and effectiveness of current stroke reperfusion therapies are limited by the complications o...
Background and Purpose—We have previously shown that the sphingosine 1-phosphate (S1P)/S1P receptor-...
Cerebral ischemia is accompanied by fulminant cellular and humoral inflammatory changes in the brain...
International audienceRationale: Cerebrovascular function is critical for brain health, and endogeno...
The two ubiquitously expressed sphingosine kinases (SphK) 1 and 2 are key regulators of the sphingol...
Collateral growth after acute occlusion of an intracranial artery is triggered by increasing shear s...
Sphingosine 1-phosphate (S1P), derived from membrane sphingolipids, is a pleiotropic bioactive lipid...
Collateral growth after acute occlusion of an intracranial artery is triggered by increasing shear s...
Sphingosine 1-phosphate (S1P), derived from membrane sphingolipids, is a pleiotropic bioactive lipid...
[Background and Purpose] Growing evidence supports that the immunomodulatory drug fingolimod is prot...
Arterial ischemic stroke is common in neonates-1 per 2,300-5,000 births-and therapeutic targets rema...
Background and Purpose Collateral growth after acute occlusion of an intracranial artery is triggere...
Acute ischemic stroke (AIS) is a neurological disease caused by cessation of blood flow to the brain...